Voglio sapere a riguardo di…

11329

Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No.
DEA794 in all correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act CSA
prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33a, DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical ingredients APIs for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities DATES:

specifically authorized by DEA
regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place.
As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823a. DEA will conduct this evaluation in the manner described in the rule published at 85 FR
82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33a, DEA is providing notice that on January 25, 2021, GGGYI LLC, 4168
South Drexel Boulevard 2A, Chicago, Illinois 60653, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled substance
Drug code
Marihuana Extract
Marihuana
Tetrahydrocannabinols

7350
7360
7370

Schedule I
I I

William T. McDermott, Assistant Administrator.
FR Doc. 202103754 Filed 22321; 8:45 am BILLING CODE 441009P

DEPARTMENT OF JUSTICE
Drug Enforcement Administration Docket No. DEA770

Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc Drug Enforcement Administration, Justice.
ACTION: Notice of application.
AGENCY:

Sigma Aldrich Research Biochemicals, Inc, has applied to be registered as a bulk manufacturer of basic classes of controlled substances. Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUMMARY:

In accordance with 21 CFR 1301.33a, this is notice that on December 17, 2020, Sigma Aldrich Research Biochemicals, Inc, 400600 Summit Drive, Burlington, Massachusetts 01803, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

SUPPLEMENTARY INFORMATION:

khammond on DSKJM1Z7X2PROD with NOTICES

Controlled substance
Drug code
Cathinone
4-Methyl-N-Methylcathinone
Methaqualone
JWH-018 & AM678
Lysergic Acid Diethylamide
Tetrahydrocannabinols
Mescaline
3,4-Methylenedioxymethamphetamine
Alpha-Methyltryptamine
Dimethyltryptamine
5-Methoxy-N,N-Diisopropyltryptamine
1-Benzylpiperazine
2-2,5-Dimethoxyphenyl Ethanamine
3,4-Methylenedioxypyrovalerone
3,4-Methylenedioxy-N-Methylcathinone
Heroin
Normorphine
Norlevorphanol
Amphetamine
Methylphenidate
Nabilone
Phencyclidine
Cocaine

VerDate Sep<11>2014

17:21 Feb 23, 2021

Jkt 253001

PO 00000

Frm 00113

Fmt 4703

Sfmt 4703

E:FRFM24FEN1.SGM

24FEN1

1235
1248
2565
7118
7315
7370
7381
7405
7432
7435
7439
7493
7517
7535
7540
9200
9313
9634
1100
1724
7379
7471
9041

Schedule I
I I
I I
I I
I I
I I
I I
I I
I I
I II
II
II
II
II